[ primary packshot ]
Precision pen on Lab White
[detail]
[scale]
[360°]
[lab]
RECOVERY & REPAIR

ZENKLOW

Four-peptide recovery blend

240 units · 3 mL pen↓ Testing

A four-peptide research blend combining BPC-157, GHK-Cu, TB-500 and KPV, synthesized to a written specification and verified at the molecular level before listing. Built from peptides studied across tissue-repair and matrix research.

Ships FREE from within Canada · No customs · no border delays.

$878.00CAD

OVERVIEW

A four-peptide blend drawn from tissue-repair research.

ZENKLOW combines four research peptides studied in connective-tissue and matrix contexts. BPC-157 is a synthetic pentadecapeptide derived from a gastric protein fragment, studied in tissue-repair models. TB-500 is a synthetic fragment of thymosin beta-4 studied in cell-migration and repair research. GHK-Cu is a copper-binding tripeptide studied in skin and matrix remodelling. KPV is a tripeptide fragment of alpha-MSH studied in research on inflammatory signalling. The blend is offered for research into these peptides together. ZENKLOW is a research-grade formulation, not an authorized medicine, and Zenovate makes no claim about its effects in humans. Every ZENKLOW batch is synthesized to a written specification and verified at [purity]% purity by an independent accredited Canadian laboratory, with the full certificate published before the batch is ever listed.

SPECIFICATIONS

ClassTissue-repair + metallopeptide (4-peptide)
Molecular weight[molecular weight]
Verified purityTested by UPLC / HPLC
FormatPrecision pen · 240u / 3 mL
Storage2–8°C, protect from light
Pen strength4 peptides · 16.67 / 3.33 mg/mL · 80 mg total
Laboratory[Independent accredited lab]

THE RESEARCH

Cited research areas: BPC-157 / TB-500 in tissue repair; GHK-Cu in matrix remodelling; KPV and melanocortin inflammatory signalling; formulation stability chemistry.

Aleksiev et al., J. Orthopedic Research (2019)Pickart et al., J. Investigative Dermatology (2014)

We cite the literature. We make no claims about effects or outcomes, and no comparison to prescription products.

[ testing methods ]
Identity · purity · stability

TESTING & QUALITY ASSURANCE

Every batch is tested before it ships.

Identity & purityUPLC / HPLC (PDA)
Mass confirmationLC-MS (ESI)
SequenceLC-MS/MS
Heavy metalsICP-MS
Water contentKarl Fischer titration
StabilityReal-time & accelerated

COMPOUND FAQ

Questions specific to ZENKLOW.

Is ZENKLOW a prescription medicine?

No. ZENKLOW is a research-grade formulation with no marketing authorization in Canada; it is not a medicine and not a substitute for one.

How do I verify what is in a ZENKLOW vial?

Every batch is tested for identity, purity and stability by an independent accredited laboratory using UPLC / HPLC, LC-MS and related methods. Our full testing methodology is published on the Lab Results page.

Why does Zenovate avoid naming prescription brands?

Because comparing a research compound to an authorized medicine would be both misleading and non-compliant; they are different categories held to different standards of evidence.

Compounded products are not evaluated by Health Canada for safety, effectiveness or quality. ZENKLOW is a research-grade formulation, not a medicine, and nothing on this page is medical advice. For adults 19 and older.